Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	extracellular matrix constituent, lubricant activity	MUC17 MUC3A MUC4	2.97e-07	4	85	3	GO:0030197
GeneOntologyMolecularFunction	extracellular matrix structural constituent	COL6A2 MXRA5 MUC17 VCAN MUC3A MUC4 MUC5AC	1.56e-05	188	85	7	GO:0005201
GeneOntologyMolecularFunction	structural molecule activity	COL6A2 MXRA5 SHANK2 ANK2 MUC17 PCLO VCAN SPTBN2 MUC3A MUC4 MUC5AC VCL	3.79e-04	891	85	12	GO:0005198
GeneOntologyCellularComponent	Golgi lumen	MUC3B MUC17 VCAN SDC3 MUC16 PPIL2 MUC5B MUC3A MUC4 MUC5AC	3.14e-11	109	88	10	GO:0005796
GeneOntologyCellularComponent	external side of plasma membrane	HEG1 MUC17 CD86 GYPB CD44 LRP1 MUC16 LY9 ECE1 IL2RG	6.50e-05	519	88	10	GO:0009897
GeneOntologyCellularComponent	apical part of cell	SHANK2 ANK2 MUC17 LMO7 SPTBN2 CNKSR3 CD44 LRP1 MUC4 SLC29A2	1.91e-04	592	88	10	GO:0045177
GeneOntologyCellularComponent	apical plasma membrane	SHANK2 ANK2 MUC17 LMO7 SPTBN2 CNKSR3 CD44 MUC4 SLC29A2	2.10e-04	487	88	9	GO:0016324
GeneOntologyCellularComponent	cell surface	HEG1 SEMA6D MUC17 LMO7 CD86 GYPB VCAN CD44 LRP1 SDC3 MUC16 LY9 ECE1 IL2RG	2.14e-04	1111	88	14	GO:0009986
GeneOntologyCellularComponent	extracellular matrix	COL6A2 MXRA5 SEMA6D MUC17 VCAN SDC3 MUC5B MUC4 MUC5AC ELFN2	4.32e-04	656	88	10	GO:0031012
GeneOntologyCellularComponent	external encapsulating structure	COL6A2 MXRA5 SEMA6D MUC17 VCAN SDC3 MUC5B MUC4 MUC5AC ELFN2	4.42e-04	658	88	10	GO:0030312
GeneOntologyCellularComponent	paranodal junction	ANK2 SPTBN2	9.40e-04	11	88	2	GO:0033010
GeneOntologyCellularComponent	side of membrane	HEG1 ANK2 MUC17 CD86 GYPB CD44 LRP1 MUC16 LY9 ECE1 IL2RG	1.10e-03	875	88	11	GO:0098552
HumanPheno	Metopic synostosis	ASXL3 GLI3 HERC1 SON	2.08e-05	28	31	4	HP:0011330
Domain	SEA	MUC3B MUC17 MUC16 MUC3A	4.05e-07	14	86	4	SM00200
Domain	SEA	MUC3B MUC17 MUC16 MUC3A	3.47e-06	23	86	4	PS50024
Domain	SEA_dom	MUC3B MUC17 MUC16 MUC3A	3.47e-06	23	86	4	IPR000082
Domain	BEACH_dom	WDR81 LRBA LYST	7.76e-06	9	86	3	IPR000409
Domain	BEACH	WDR81 LRBA LYST	7.76e-06	9	86	3	PS50197
Domain	Beach	WDR81 LRBA LYST	7.76e-06	9	86	3	PF02138
Domain	-	WDR81 LRBA LYST	7.76e-06	9	86	3	1.10.1540.10
Domain	Beach	WDR81 LRBA LYST	7.76e-06	9	86	3	SM01026
Domain	EGF_3	CELSR1 MUC3B HEG1 MUC17 VCAN LRP1 MUC3A MUC4	1.27e-05	235	86	8	PS50026
Domain	EGF	CELSR1 MUC3B HEG1 MUC17 VCAN LRP1 MUC3A MUC4	1.27e-05	235	86	8	SM00181
Domain	EGF-like_dom	CELSR1 MUC3B HEG1 MUC17 VCAN LRP1 MUC3A MUC4	1.93e-05	249	86	8	IPR000742
Domain	EGF_1	CELSR1 MUC3B HEG1 MUC17 VCAN LRP1 MUC3A MUC4	2.29e-05	255	86	8	PS00022
Domain	EGF-like_CS	CELSR1 MUC3B HEG1 MUC17 VCAN LRP1 MUC3A MUC4	2.71e-05	261	86	8	IPR013032
Domain	EGF_2	CELSR1 MUC3B HEG1 MUC17 VCAN LRP1 MUC3A MUC4	3.02e-05	265	86	8	PS01186
Domain	VWD	MUC5B MUC4 MUC5AC	5.05e-05	16	86	3	SM00216
Domain	VWF_type-D	MUC5B MUC4 MUC5AC	5.05e-05	16	86	3	IPR001846
Domain	VWFD	MUC5B MUC4 MUC5AC	5.05e-05	16	86	3	PS51233
Domain	VWD	MUC5B MUC4 MUC5AC	5.05e-05	16	86	3	PF00094
Domain	SEA	MUC3B MUC17 MUC16	1.36e-04	22	86	3	PF01390
Domain	EGF	CELSR1 HEG1 VCAN LRP1 MUC4	2.90e-04	126	86	5	PF00008
Domain	PH_BEACH	LRBA LYST	3.11e-04	6	86	2	PF14844
Domain	WxxW_domain	MUC5B MUC5AC	3.11e-04	6	86	2	IPR025155
Domain	Mucin2_WxxW	MUC5B MUC5AC	3.11e-04	6	86	2	PF13330
Domain	PH-BEACH_dom	LRBA LYST	5.76e-04	8	86	2	IPR023362
Domain	-	LRBA LYST	5.76e-04	8	86	2	2.30.29.40
Domain	PH_BEACH	LRBA LYST	5.76e-04	8	86	2	PS51783
Domain	PDZ	SHANK2 LMO7 PCLO CNKSR3 APBA2	6.65e-04	151	86	5	PS50106
Domain	PDZ	SHANK2 LMO7 PCLO CNKSR3 APBA2	6.85e-04	152	86	5	IPR001478
Domain	ASX_HYDROXYL	CELSR1 HEG1 VCAN LRP1	1.17e-03	100	86	4	PS00010
Domain	TIL	MUC5B MUC5AC	1.34e-03	12	86	2	PF01826
Domain	C8	MUC5B MUC5AC	1.34e-03	12	86	2	PF08742
Domain	EGF-type_Asp/Asn_hydroxyl_site	CELSR1 HEG1 VCAN LRP1	1.46e-03	106	86	4	IPR000152
Domain	LINK	VCAN CD44	1.58e-03	13	86	2	SM00445
Domain	Unchr_dom_Cys-rich	MUC5B MUC5AC	1.58e-03	13	86	2	IPR014853
Domain	Link_dom	VCAN CD44	1.58e-03	13	86	2	IPR000538
Domain	C8	MUC5B MUC5AC	1.58e-03	13	86	2	SM00832
Domain	Xlink	VCAN CD44	1.58e-03	13	86	2	PF00193
Domain	LINK_1	VCAN CD44	1.58e-03	13	86	2	PS01241
Domain	LINK_2	VCAN CD44	1.58e-03	13	86	2	PS50963
Domain	TIL_dom	MUC5B MUC5AC	1.84e-03	14	86	2	IPR002919
Domain	Glyco_hormone_CN	MUC5B MUC5AC	2.12e-03	15	86	2	IPR006208
Domain	Cys_knot	MUC5B MUC5AC	2.12e-03	15	86	2	PF00007
Domain	-	MUC17 MUC16	2.12e-03	15	86	2	3.30.70.960
Domain	EGF_CA	CELSR1 HEG1 VCAN LRP1	2.44e-03	122	86	4	SM00179
Domain	EGF-like_Ca-bd_dom	CELSR1 HEG1 VCAN LRP1	2.58e-03	124	86	4	IPR001881
Domain	CTCK_1	MUC5B MUC5AC	3.06e-03	18	86	2	PS01185
Domain	VWC_out	MUC5B MUC5AC	3.41e-03	19	86	2	SM00215
Domain	-	ZBTB49 KLF8 GZF1 ZNF532 KLF1 GLI3 ZNF596 ZNF507 ZNF521	4.00e-03	679	86	9	3.30.160.60
Domain	PDZ	SHANK2 LMO7 CNKSR3 APBA2	4.10e-03	141	86	4	PF00595
Domain	-	SEMA6D WDR81 LRBA HERC1 LYST SON	4.37e-03	333	86	6	2.130.10.10
Domain	WD40/YVTN_repeat-like_dom	SEMA6D WDR81 LRBA HERC1 LYST SON	4.50e-03	335	86	6	IPR015943
Domain	CT	MUC5B MUC5AC	4.56e-03	22	86	2	SM00041
Domain	Znf_C2H2/integrase_DNA-bd	ZBTB49 KLF8 GZF1 ZNF532 KLF1 GLI3 ZNF596 ZNF507 ZNF521	4.61e-03	694	86	9	IPR013087
Domain	PDZ	SHANK2 LMO7 CNKSR3 APBA2	4.86e-03	148	86	4	SM00228
Domain	-	SHANK2 LMO7 CNKSR3 APBA2	5.10e-03	150	86	4	2.30.42.10
Domain	Cys_knot_C	MUC5B MUC5AC	5.87e-03	25	86	2	IPR006207
Domain	CTCK_2	MUC5B MUC5AC	5.87e-03	25	86	2	PS01225
Domain	VWC	MUC5B MUC5AC	7.33e-03	28	86	2	PF00093
Pathway	REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC	MUC17 MUC16 MUC5B MUC3A MUC4 MUC5AC	2.88e-11	16	58	6	M27410
Pathway	REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS	MUC17 MUC16 MUC5B MUC3A MUC4 MUC5AC	4.44e-11	17	58	6	M27412
Pathway	REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS	MUC17 MUC16 MUC5B MUC3A MUC4 MUC5AC	3.56e-10	23	58	6	M556
Pathway	REACTOME_DECTIN_2_FAMILY	MUC17 MUC16 MUC5B MUC3A MUC4 MUC5AC	8.03e-10	26	58	6	M27483
Pathway	REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS	MUC17 MUC16 MUC5B MUC4 MUC5AC	1.91e-08	21	58	5	MM15706
Pathway	REACTOME_DISEASES_OF_GLYCOSYLATION	MUC17 VCAN SDC3 MUC16 MUC5B MUC3A MUC4 MUC5AC	1.15e-07	143	58	8	M27275
Pathway	REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS	MUC17 MUC16 MUC5B MUC3A MUC4 MUC5AC	1.91e-07	62	58	6	M546
Pathway	REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS	MUC17 MUC16 MUC5B MUC3A MUC4 MUC5AC	3.34e-07	68	58	6	M27303
Pathway	REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS	MUC17 MUC16 MUC5B MUC4 MUC5AC	4.54e-06	60	58	5	MM15636
Pathway	REACTOME_O_LINKED_GLYCOSYLATION	MUC17 MUC16 MUC5B MUC3A MUC4 MUC5AC	6.04e-06	111	58	6	M27416
Pathway	REACTOME_DISEASES_OF_METABOLISM	MUC17 VCAN SDC3 MUC16 MUC5B MUC3A MUC4 MUC5AC	7.80e-06	250	58	8	M27554
Pathway	REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS	MUC17 MUC16 MUC5B MUC3A MUC4 MUC5AC	2.28e-05	140	58	6	M27484
Pathway	REACTOME_O_LINKED_GLYCOSYLATION	MUC17 MUC16 MUC5B MUC4 MUC5AC	8.34e-05	109	58	5	MM15164
Pathway	REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION	USP2 FBXL7 ANK2 MUC17 LMO7 POLB VCAN SPTBN2 NR4A2 MUC16 MUC5B GOSR2 MUC3A MUC4 MUC5AC	7.07e-04	1475	58	15	M19806
Pubmed	Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux.	MUC17 MUC16 MUC5B MUC3A MUC4 MUC5AC	4.91e-12	18	91	6	18834073
Pubmed	Expression of mucin 3 and mucin 5AC in arthritic synovial tissue.	MUC3B MUC3A MUC5AC	1.73e-08	3	91	3	18163520
Pubmed	Genomic organization and structure of the 3' region of human MUC3: alternative splicing predicts membrane-bound and soluble forms of the mucin.	MUC3B MUC17 MUC3A	1.73e-08	3	91	3	10512748
Pubmed	Polymorphism of human mucin genes in chest disease: possible significance of MUC2.	MUC5B MUC4 MUC5AC	1.73e-07	5	91	3	11062147
Pubmed	Expression of Muc19/Smgc gene products during murine sublingual gland development: cytodifferentiation and maturation of salivary mucous cells.	MUC16 MUC5B MUC5AC	3.45e-07	6	91	3	19110483
Pubmed	Shotgun sequencing of the human transcriptome with ORF expressed sequence tags.	SHANK2 LMO7 PCDHGA7 ASXL3 CD44 NVL MUC16 ZSWIM6 MUC3A LYST	1.90e-06	552	91	10	10737800
Pubmed	SLAMF7 is critical for phagocytosis of haematopoietic tumour cells via Mac-1 integrin.	LRP1 LY9 IL2RG	6.18e-06	14	91	3	28424516
Pubmed	Cloning and analysis of cDNA encoding a major airway glycoprotein, human tracheobronchial mucin (MUC5).	MUC5B MUC5AC	6.77e-06	2	91	2	7513696
Pubmed	Hyaluronan fragments/CD44 mediate oxidative stress-induced MUC5B up-regulation in airway epithelium.	CD44 MUC5B	6.77e-06	2	91	2	18757307
Pubmed	Airway mucin MUC5AC and MUC5B concentrations and the initiation and progression of chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort.	MUC5B MUC5AC	6.77e-06	2	91	2	34058148
Pubmed	The association between MUC5AC and MUC5B genes expression and remodeling progression in severe neutrophilic asthma: A direct relationship.	MUC5B MUC5AC	6.77e-06	2	91	2	37146737
Pubmed	MUC5AC and MUC5B Mucins Are Decreased in Cystic Fibrosis Airway Secretions.	MUC5B MUC5AC	6.77e-06	2	91	2	14988081
Pubmed	Mucin glycosylation changes in cystic fibrosis lung disease are not manifest in submucosal gland secretions.	MUC5B MUC5AC	6.77e-06	2	91	2	15563276
Pubmed	Alterations of the ocular surface epithelial MUC16 and goblet cell MUC5AC in patients with atopic keratoconjunctivitis.	MUC16 MUC5AC	6.77e-06	2	91	2	18782111
Pubmed	Initiation of transcription of the MUC3A human intestinal mucin from a TATA-less promoter and comparison with the MUC3B amino terminus.	MUC3B MUC3A	6.77e-06	2	91	2	12958310
Pubmed	The expression of MUC5AC and MUC5B mucin genes in the mucosa of chronic rhinosinusitis and nasal polyposis.	MUC5B MUC5AC	6.77e-06	2	91	2	17621824
Pubmed	MUC4 and MUC5AC are highly specific tumour-associated mucins in biliary tract cancer.	MUC4 MUC5AC	6.77e-06	2	91	2	18475301
Pubmed	Enhanced discrimination of malignant from benign pancreatic disease by measuring the CA 19-9 antigen on specific protein carriers.	MUC16 MUC5AC	6.77e-06	2	91	2	22220206
Pubmed	Muc5b is required for airway defence.	MUC5B MUC5AC	6.77e-06	2	91	2	24317696
Pubmed	Macrophages are related to goblet cell hyperplasia and induce MUC5B but not MUC5AC in human bronchus epithelial cells.	MUC5B MUC5AC	6.77e-06	2	91	2	22391959
Pubmed	C-Mannosylation of MUC5AC and MUC5B Cys subdomains.	MUC5B MUC5AC	6.77e-06	2	91	2	14718370
Pubmed	Mucins MUC5AC and MUC5B Are Variably Packaged in the Same and in Separate Secretory Granules.	MUC5B MUC5AC	6.77e-06	2	91	2	35776514
Pubmed	TRAPPC11 and GOSR2 mutations associate with hypoglycosylation of α-dystroglycan and muscular dystrophy.	TRAPPC11 GOSR2	6.77e-06	2	91	2	29855340
Pubmed	Variation in RTN3 and PPIL2 genes does not influence platelet membrane beta-secretase activity or susceptibility to alzheimer's disease in the northern Irish population.	RTN3 PPIL2	6.77e-06	2	91	2	19669607
Pubmed	Bypass of lethality with mosaic mice generated by Cre-loxP-mediated recombination.	POLB IL2RG	6.77e-06	2	91	2	8939573
Pubmed	The ocular surface phenotype of Muc5ac and Muc5b null mice.	MUC5B MUC5AC	6.77e-06	2	91	2	24327612
Pubmed	LRP-1--CD44, a new cell surface complex regulating tumor cell adhesion.	CD44 LRP1	6.77e-06	2	91	2	22711991
Pubmed	Mucin production during prenatal and postnatal murine lung development.	MUC5B MUC5AC	6.77e-06	2	91	2	21653907
Pubmed	MUC5B mobilizes and MUC5AC spatially aligns mucociliary transport on human airway epithelium.	MUC5B MUC5AC	6.77e-06	2	91	2	36427316
Pubmed	Molecular implications of MUC5AC-CD44 axis in colorectal cancer progression and chemoresistance.	CD44 MUC5AC	6.77e-06	2	91	2	32098629
Pubmed	Gel-forming mucins form distinct morphologic structures in airways.	MUC5B MUC5AC	6.77e-06	2	91	2	28607090
Pubmed	Multiple transcripts of MUC3: evidence for two genes, MUC3A and MUC3B.	MUC3B MUC3A	6.77e-06	2	91	2	10973822
Pubmed	Mucin deficiency causes functional and structural changes of the ocular surface.	MUC5B MUC5AC	6.77e-06	2	91	2	23272068
Pubmed	Muc5b is mainly expressed and sialylated in the nasal olfactory epithelium whereas Muc5ac is exclusively expressed and fucosylated in the nasal respiratory epithelium.	MUC5B MUC5AC	6.77e-06	2	91	2	31030254
Pubmed	Versican and CD44 in in vitro valvular interstitial cell injury and repair.	VCAN CD44	6.77e-06	2	91	2	21546273
Pubmed	Younger patients with COME are more likely to have mucoid middle ear fluid containing mucin MUC5B.	MUC5B MUC5AC	6.77e-06	2	91	2	27729120
Pubmed	MUC3 human intestinal mucin. Analysis of gene structure, the carboxyl terminus, and a novel upstream repetitive region.	MUC3B MUC3A	6.77e-06	2	91	2	9334251
Pubmed	The idiopathic pulmonary fibrosis honeycomb cyst contains a mucocilary pseudostratified epithelium.	MUC5B MUC5AC	6.77e-06	2	91	2	23527003
Pubmed	Up-regulation of MUC5AC and MUC5B mucin genes in nasopharyngeal respiratory mucosa and selective up-regulation of MUC5B in middle ear in pediatric otitis media with effusion.	MUC5B MUC5AC	6.77e-06	2	91	2	16540890
Pubmed	Differential gene expression profile in PBMCs from subjects with AERD and ATA: a gene marker for AERD.	SPTBN2 CNKSR3	6.77e-06	2	91	2	22457146
Pubmed	De novo NUF2 variant in a novel inherited bone marrow failure syndrome including microcephaly and renal hypoplasia.	MUC5B MUC5AC	6.77e-06	2	91	2	36111525
Pubmed	Role of versican V0/V1 and CD44 in the regulation of human melanoma cell behavior.	VCAN CD44	6.77e-06	2	91	2	21136024
Pubmed	Abnormalities in MUC5AC and MUC5B Protein in Airway Mucus in Asthma.	MUC5B MUC5AC	6.77e-06	2	91	2	27845589
Pubmed	Molecular cloning of cDNAs derived from a novel human intestinal mucin gene.	MUC3B MUC3A	6.77e-06	2	91	2	2393399
Pubmed	Associations of distinct variants of the intestinal mucin gene MUC3A with ulcerative colitis and Crohn's disease.	MUC3B MUC3A	6.77e-06	2	91	2	11289722
Pubmed	Contribution of mucus concentration and secreted mucins Muc5ac and Muc5b to the pathogenesis of muco-obstructive lung disease.	MUC5B MUC5AC	6.77e-06	2	91	2	27435107
Pubmed	Immunocytochemistry for MUC4 and MUC16 is a useful adjunct in the diagnosis of pancreatic adenocarcinoma on fine-needle aspiration cytology.	MUC16 MUC4	6.77e-06	2	91	2	23544943
Pubmed	Mucins MUC5B and MUC5AC in Distal Airways and Honeycomb Spaces: Comparison among Idiopathic Pulmonary Fibrosis/Usual Interstitial Pneumonia, Fibrotic Nonspecific Interstitial Pneumonitis, and Control Lungs.	MUC5B MUC5AC	6.77e-06	2	91	2	26871672
Pubmed	Expression of mucins in mucoid otitis media.	MUC5B MUC4	6.77e-06	2	91	2	14690056
Pubmed	CD44 adhesion molecule and neuro-glial proteoglycan NG2 as invasive markers of glioma.	VCAN CD44	6.77e-06	2	91	2	17957481
Pubmed	Normal murine respiratory tract has its mucus concentrated in clouds based on the Muc5b mucin.	MUC5B MUC5AC	6.77e-06	2	91	2	32348677
Pubmed	In silico cloning of mouse Muc5b gene and upregulation of its expression in mouse asthma model.	MUC5B MUC5AC	6.77e-06	2	91	2	11587997
Pubmed	Alteration of ocular surface mucins in MUC5AC-DTA transgenic mice.	MUC4 MUC5AC	6.77e-06	2	91	2	19158956
Pubmed	Pathobiological implications of mucin (MUC) expression in the outcome of small bowel cancer.	MUC16 MUC5AC	6.77e-06	2	91	2	24722639
Pubmed	Reassessment of the importance of mucins in determining sputum properties in cystic fibrosis.	MUC5B MUC5AC	6.77e-06	2	91	2	24332705
Pubmed	The MUC3 gene encodes a transmembrane mucin and is alternatively spliced.	MUC3B MUC3A	6.77e-06	2	91	2	10405327
Pubmed	Pathophysiological relevance of sputum MUC5AC and MUC5B levels in patients with mild asthma.	MUC5B MUC5AC	6.77e-06	2	91	2	34656442
Pubmed	Chromosomal organization of candidate genes involved in cholesterol gallstone formation: a murine gallstone map.	MUC17 LRP1 MUC5B MUC5AC	7.18e-06	47	91	4	11208732
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	TAOK2 FBXL7 SMG7 ZNF532 LMO7 PLCH2 ZNF507 KIAA1549 SDC3	1.06e-05	529	91	9	14621295
Pubmed	Assessment of mucin-related gene alterations following treatment with rebamipide ophthalmic suspension in Sjögren's syndrome-associated dry eyes.	MUC16 MUC5AC	2.03e-05	3	91	2	33232357
Pubmed	Interleukin-33 induces mucin gene expression and goblet cell hyperplasia in human nasal epithelial cells.	MUC5B MUC5AC	2.03e-05	3	91	2	27776277
Pubmed	Microbial products alter the expression of membrane-associated mucin and antimicrobial peptides in a three-dimensional human endocervical epithelial cell model.	MUC16 MUC4	2.03e-05	3	91	2	23053434
Pubmed	A network of Krüppel-like Factors (Klfs). Klf8 is repressed by Klf3 and activated by Klf1 in vivo.	KLF8 KLF1	2.03e-05	3	91	2	18687676
Pubmed	Prognostic significance of CA 125, CD44, and epithelial membrane antigen in renal cell carcinoma.	CD44 MUC16	2.03e-05	3	91	2	12893366
Pubmed	High-Mobility Group Box 1 Upregulates MUC5AC and MUC5B Expression in Primary Airway Epithelial Cells.	MUC5B MUC5AC	2.03e-05	3	91	2	29286856
Pubmed	DUSP28 links regulation of Mucin 5B and Mucin 16 to migration and survival of AsPC-1 human pancreatic cancer cells.	MUC16 MUC5B	2.03e-05	3	91	2	27230679
Pubmed	Integrative analysis of the cancer genome atlas and cancer cell lines encyclopedia large-scale genomic databases: MUC4/MUC16/MUC20 signature is associated with poor survival in human carcinomas.	MUC16 MUC4	2.03e-05	3	91	2	30236127
Pubmed	Nebulized Menthol Impairs Mucociliary Clearance via TRPM8 and MUC5AC/MUC5B in Primary Airway Epithelial Cells.	MUC5B MUC5AC	2.03e-05	3	91	2	36675209
Pubmed	Regulation of membrane-associated mucins in the human corneal epithelial cells by dexamethasone.	MUC16 MUC4	2.03e-05	3	91	2	17592322
Pubmed	Th2 cytokines orchestrate the secretion of MUC5AC and MUC5B in IL-5-positive chronic rhinosinusitis with nasal polyps.	MUC5B MUC5AC	2.03e-05	3	91	2	29802623
Pubmed	V3 versican isoform alters the behavior of human melanoma cells by interfering with CD44/ErbB-dependent signaling.	VCAN CD44	2.03e-05	3	91	2	21078678
Pubmed	Two atypical enteropathogenic Escherichia coli strains induce the production of secreted and membrane-bound mucins to benefit their own growth at the apical surface of human mucin-secreting intestinal HT29-MTX cells.	MUC17 MUC4	2.03e-05	3	91	2	20065027
Pubmed	Autophagy of mucin granules contributes to resolution of airway mucous metaplasia.	MUC5B MUC5AC	2.03e-05	3	91	2	34158522
Pubmed	Resistin upregulates MUC5AC/B mucin gene expression in human airway epithelial cells.	MUC5B MUC5AC	2.03e-05	3	91	2	29604272
Pubmed	IL-8 regulates mucin gene expression at the posttranscriptional level in lung epithelial cells.	MUC5B MUC5AC	2.03e-05	3	91	2	19596978
Pubmed	Genome-wide bidirectional CRISPR screens identify mucins as host factors modulating SARS-CoV-2 infection.	MUC16 MUC4	2.03e-05	3	91	2	35879412
Pubmed	Hyaluronan and its binding proteins during cervical ripening and parturition: dynamic changes in size, distribution and temporal sequence.	VCAN CD44	2.03e-05	3	91	2	18353623
Pubmed	Regulation of neuregulin 1beta1-induced MUC5AC and MUC5B expression in human airway epithelium.	MUC5B MUC5AC	2.03e-05	3	91	2	19556605
Pubmed	Clinicopathological and prognostic significance of MUC-2, MUC-4 and MUC-5AC expression in japanese gastric carcinomas.	MUC4 MUC5AC	2.03e-05	3	91	2	23464473
Pubmed	Aquaporin 5 expression increases mucin production in lung adenocarcinoma.	MUC5B MUC5AC	2.03e-05	3	91	2	21455588
Pubmed	Expression of leptin receptor in nasal polyps: leptin as a mucosecretagogue.	MUC5B MUC5AC	2.03e-05	3	91	2	20422702
Pubmed	Functional Consequences of Differential O-glycosylation of MUC1, MUC4, and MUC16 (Downstream Effects on Signaling).	MUC16 MUC4	2.03e-05	3	91	2	27483328
Pubmed	MicroRNA-200c modulates the expression of MUC4 and MUC16 by directly targeting their coding sequences in human pancreatic cancer.	MUC16 MUC4	2.03e-05	3	91	2	24204560
Pubmed	Expression of the transmembrane mucins, MUC1, MUC4 and MUC16, in normal endometrium and in endometriosis.	MUC16 MUC4	2.03e-05	3	91	2	24939955
Pubmed	Mucin gene polymorphisms in otitis media patients.	MUC5B MUC5AC	2.03e-05	3	91	2	19718741
Pubmed	E-cadherin is required for intestinal morphogenesis in the mouse.	MUC17 CD44 MUC4	3.37e-05	24	91	3	22766025
Pubmed	HIV-1 mediated immune pathogenesis: spotlight on the role of viral protein R (Vpr).	CCNT1 CD86 CD44	3.82e-05	25	91	3	19275586
Pubmed	ILC2s mediate systemic innate protection by priming mucus production at distal mucosal sites.	MUC5B MUC5AC	4.05e-05	4	91	2	31582416
Pubmed	Increased expression of MUC5AC and MUC5B promoting bacterial biofilm formation in chronic rhinosinusitis patients.	MUC5B MUC5AC	4.05e-05	4	91	2	25638393
Pubmed	Epigenetic regulation (DNA methylation, histone modifications) of the 11p15 mucin genes (MUC2, MUC5AC, MUC5B, MUC6) in epithelial cancer cells.	MUC5B MUC5AC	4.05e-05	4	91	2	17471237
Pubmed	Positional cloning of the Chediak-Higashi syndrome gene: genetic mapping of the beige locus on mouse chromosome 13.	GLI3 LYST	4.05e-05	4	91	2	8952226
Pubmed	MCP-1/CCR2B-dependent loop upregulates MUC5AC and MUC5B in human airway epithelium.	MUC5B MUC5AC	4.05e-05	4	91	2	21097527
Pubmed	Expression of MUC1, MUC2, MUC5AC and MUC5B in mucinous lesions of the breast.	MUC5B MUC5AC	4.05e-05	4	91	2	22269464
Pubmed	The mouse secreted gel-forming mucin gene cluster.	MUC5B MUC5AC	4.05e-05	4	91	2	14984930
Pubmed	TGF-β₂ decreases baseline and IL-13-stimulated mucin production by primary human bronchial epithelial cells.	MUC5B MUC5AC	4.05e-05	4	91	2	23249391
Pubmed	Effects of the Helicobacter pylori Virulence Factor CagA and Ammonium Ion on Mucins in AGS Cells.	MUC5B MUC5AC	4.05e-05	4	91	2	29869461
Pubmed	Munc13-2-/- baseline secretion defect reveals source of oligomeric mucins in mouse airways.	MUC5B MUC5AC	4.05e-05	4	91	2	18258655
Pubmed	Binding of a large chondroitin sulfate/dermatan sulfate proteoglycan, versican, to L-selectin, P-selectin, and CD44.	VCAN CD44	4.05e-05	4	91	2	10950950
Pubmed	Expression of MUC2, MUC5AC, MUC5B, and MUC6 mucins in colorectal cancers and their association with the CpG island methylator phenotype.	MUC5B MUC5AC	4.05e-05	4	91	2	23807779
Pubmed	TRPV4 activation in human corneal epithelial cells promotes membrane mucin production.	MUC16 MUC4	4.05e-05	4	91	2	39024979
Cytoband	7q22	MUC3B MUC3A CNOT4	6.04e-05	38	91	3	7q22
Cytoband	11q13	SPTBN2 RTN3 C11orf24 SLC29A2	9.33e-05	118	91	4	11q13
Cytoband	Ensembl 112 genes in cytogenetic band chr11q13	SHANK2 SPTBN2 RTN3 C11orf24 SLC29A2	2.14e-03	454	91	5	chr11q13
GeneFamily	CD molecules\|Mucins	MUC3B MUC17 MUC16 MUC5B MUC22 MUC3A MUC4 MUC5AC	6.53e-15	21	70	8	648
GeneFamily	WD repeat domain containing\|BEACH domain containing	WDR81 LRBA LYST	4.59e-06	9	70	3	1230
GeneFamily	PDZ domain containing	SHANK2 LMO7 PCLO CNKSR3 APBA2	3.07e-04	152	70	5	1220
GeneFamily	ADAM metallopeptidase domain containing\|CD molecules	CD86 GYPB CD101 CD44 LRP1 LY9 IL2RG	8.15e-04	394	70	7	471
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZBTB49 KLF8 GZF1 ZNF532 KLF1 GLI3 ZNF596 ZNF507 ZNF521	1.74e-03	718	70	9	28
GeneFamily	Zinc fingers C2H2-type\|Kruppel like factors	KLF8 KLF1	2.17e-03	18	70	2	624
Coexpression	NABA_ECM_AFFILIATED	SEMA6D MUC17 SDC3 MUC16 MUC5B MUC22 MUC3A MUC4 MUC5AC ELFN2	3.30e-10	170	89	10	M5880
Coexpression	NABA_ECM_AFFILIATED	SEMA6D MUC17 SDC3 MUC16 MUC5B MUC4 MUC5AC ELFN2	6.81e-08	158	89	8	MM17063
Coexpression	NAKAYA_B_CELL_FLUMIST_AGE_18_50YO_7DY_DN	KLF8 ZNF532 CD86 CD44 ECE1 GOSR2 CNOT4 SON SLC35F5	8.71e-06	399	89	9	M40939
Coexpression	XIE_TRASTUZUMAB_CARDIOTOXICITY_CIRCRNA_GENES	R3HCC1L ANK2 CNKSR3 SLC35F5	1.03e-05	40	89	4	MM17488
Coexpression	HEVNER_CORTEX_APICAL_AND_BASAL_INTERMEDIATE_PROGENITOR_CELLS	CELSR1 BAZ2B SDC3 NCKAP5	3.71e-05	55	89	4	MM397
Coexpression	NABA_MATRISOME	COL6A2 MXRA5 SEMA6D MUC17 VCAN SDC3 MUC16 MUC5B MUC22 MUC3A MUC4 MUC5AC ELFN2	4.19e-05	1026	89	13	M5889
Coexpression	BYSTROEM_CORRELATED_WITH_IL5_DN	CD44 NVL TMPO LYST	5.24e-05	60	89	4	M1401
Coexpression	GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS	COL6A2 HEG1 MXRA5 FBXL7 GLI3 VCAN LRP1 ZNF521 SDC3	5.53e-05	505	89	9	M39167
Coexpression	GSE3982_MEMORY_CD4_TCELL_VS_TH2_UP	TRAPPC11 CELSR1 CD44 HERC1 LY9 DOP1A	5.62e-05	196	89	6	M5381
Coexpression	HE_LIM_SUN_FETAL_LUNG_C6_MUC16_POS_CILIATED_CELL	VCAN MUC16 SCPEP1 MUC4	5.96e-05	62	89	4	M45790
Coexpression	GSE43863_DAY6_EFF_VS_DAY150_MEM_TH1_CD4_TCELL_UP	USP2 CD86 NR4A2 WDR81 IL2RG VCL	6.29e-05	200	89	6	M9742
Coexpression	GSE42088_UNINF_VS_LEISHMANIA_INF_DC_24H_UP	CD86 POLB VCAN NR4A2 SCPEP1 DOP1A	6.29e-05	200	89	6	M9895
Coexpression	MEISSNER_NPC_ICP_WITH_H3_UNMETHYLATED	COL6A2 SHANK2 NCKAP5	6.38e-05	23	89	3	M1937
Coexpression	MEISSNER_NPC_ICP_WITH_H3_UNMETHYLATED	COL6A2 SHANK2 NCKAP5	6.38e-05	23	89	3	MM821
Coexpression	HE_LIM_SUN_FETAL_LUNG_C1_PROXIMAL_SECRETORY_2_CELL	COL6A2 VCAN SPTBN2 NR4A2 MUC16 MUC5B MUC4	7.57e-05	301	89	7	M45708
Coexpression	HEVNER_CORTICAL_PLATE_POSTMITOTIC_NEURONS	ANK2 ASXL3 PCLO APBA2 KIAA1549	1.02e-04	136	89	5	MM407
Coexpression	BYSTROEM_CORRELATED_WITH_IL5_DN	CD44 NVL TMPO LYST	1.26e-04	75	89	4	MM605
Coexpression	MEISSNER_BRAIN_ICP_WITH_H3K4ME3	COL6A2 SHANK2 NCKAP5	1.59e-04	31	89	3	M1939
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HDA1	SHANK2 SEMA6D ANK2 ASXL3 KCTD8 NR4A2 SDC3 ZSWIM6 ELFN2	1.66e-04	584	89	9	M39068
Coexpression	MEISSNER_ES_ICP_WITH_H3K4ME3	COL6A2 SHANK2 NCKAP5	1.75e-04	32	89	3	M1929
Coexpression	MEISSNER_BRAIN_ICP_WITH_H3K4ME3	COL6A2 SHANK2 NCKAP5	1.75e-04	32	89	3	MM823
Coexpression	MEISSNER_ES_ICP_WITH_H3K4ME3	COL6A2 SHANK2 NCKAP5	1.92e-04	33	89	3	MM815
Coexpression	PEREZ_TP53_TARGETS	HEG1 MXRA5 FAM106A LMO7 VCAN CNKSR3 KIAA1549 ZSWIM6 ECE1 LRRC37B MUC5AC ELFN2 DOP1A	2.03e-04	1201	89	13	M4391
CoexpressionAtlas	dev gonad_e12.5_F_DevVasOvary_Flk_k-means-cluster#3_top-relative-expression-ranked_500	HEG1 FBXL7 SEMA6D NR4A2 ZNF521	7.98e-06	66	88	5	gudmap_dev gonad_e12.5_F_gudmap_devVasOvary_Flk_k3_500
CoexpressionAtlas	facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2	USP2 CACNG7 FBXL7 SEMA6D ASXL3 GLI3 VCAN CD44 NR4A2 LRP1 ZNF521 KIAA1549 C11orf24 SCPEP1 CNOT4 DOP1A	3.26e-05	1208	88	16	facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2
ToppCell	nucseq-Epithelial-Epithelial_Glandular\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MUC17 MUC16 MUC5B MUC3A MUC4 MUC5AC MGAM2	7.93e-08	179	90	7	859cd8ee414ad6207c046ada2e655e49322dd01c
ToppCell	nucseq-Epithelial-Epithelial_Glandular-Goblet\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MUC17 MUC16 MUC5B MUC3A MUC4 MUC5AC MGAM2	8.24e-08	180	90	7	3dc80bc636bf0e6ffc9762853132a9fe59fd1f66
ToppCell	nucseq-Epithelial-Epithelial_Glandular-Goblet-Goblet\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MUC17 MUC16 MUC5B MUC3A MUC4 MUC5AC MGAM2	8.24e-08	180	90	7	668a2d8e1d5a390309d5eb62c836f5903144bea9
ToppCell	Control-Epithelial_cells-Airway_mucous\|Control / group, cell type (main and fine annotations)	MUC17 MUC16 MUC5B MUC3A MUC4 MUC5AC MGAM2	9.23e-08	183	90	7	15d24a4fb1ffe6cbafbd54fcd7dde9ddcfbe03b2
ToppCell	Control-Epithelial_cells-Airway_goblet\|Control / group, cell type (main and fine annotations)	MUC17 MUC16 MUC5B MUC3A MUC4 MUC5AC MGAM2	9.58e-08	184	90	7	d92a71441e4e19f8c301999d8186f8e48e3cd162
ToppCell	Control-Fibroblasts-Adventitial_FB\|Control / group, cell type (main and fine annotations)	COL6A2 PHLDB1 FBXL7 ANK2 VCAN LRP1 ZNF521	1.11e-07	188	90	7	706a26c372add839d947749f0521a0e1f5c9b0ec
ToppCell	COVID-19-Epithelial_cells-Airway_goblet\|COVID-19 / group, cell type (main and fine annotations)	CELSR1 SHANK2 LMO7 MUC16 MUC5B MUC4 MUC5AC	1.19e-07	190	90	7	51ca9ef4df3220487152fcf684147730637c7cc1
ToppCell	COVID-19-lung-Secretory\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CELSR1 SHANK2 LMO7 PLCH2 MUC5B MUC4 MUC5AC	1.28e-07	192	90	7	59261098ccb52306f837f632ebaea45b90ad30fe
ToppCell	Bronchial-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Goblet\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ASXL3 TMEM63C MUC16 MUC5B MUC4 MUC5AC CCDC33	1.37e-07	194	90	7	e0228f593c3493175962a4817500d4337ddc4e88
ToppCell	Control-Fibroblasts-Intermediate_pathological_FB\|Control / group, cell type (main and fine annotations)	COL6A2 MXRA5 FBXL7 ANK2 GLI3 VCAN ZNF521	1.37e-07	194	90	7	03a269f75a481ea54aea8e6444605db8d6df493d
ToppCell	LA-02._Fibroblast_II\|LA / Chamber and Cluster_Paper	COL6A2 PHLDB1 FBXL7 VCAN LRP1 ZNF521 ECE1	1.37e-07	194	90	7	234d1494c114cce77c619708bbcd8d5ce805f19b
ToppCell	LA-02._Fibroblast_II\|World / Chamber and Cluster_Paper	COL6A2 PHLDB1 FBXL7 VCAN LRP1 ZNF521 ECE1	1.42e-07	195	90	7	a78b605b49acd8c9d68716266ca269dafcd910b9
ToppCell	Control-Classical_Monocyte-cMono_2\|Control / Disease condition and Cell class	BAZ2B VCAN CD44 NR4A2 LRP1 RTN3 SCPEP1	1.42e-07	195	90	7	0fea64ee3eedf3929abb0dd9c5f5fc72f181eed9
ToppCell	Bronchial-NucSeq-Epithelial-Epi_airway_secretory\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CELSR1 SHANK2 TMEM63C MUC16 MUC5B MUC4 MUC5AC	1.42e-07	195	90	7	e7230a849ea31e6eef9bc6f5468938499450582d
ToppCell	Fibroblasts\|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	COL6A2 PHLDB1 MXRA5 ANK2 GLI3 VCAN LRP1	1.63e-07	199	90	7	40de6d4a31cf22efa2864f79e4ec8e2b7bfc9d4a
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	TAOK2 HEG1 BAZ2B ZNF521 NCKAP5 ECE1 SON	1.69e-07	200	90	7	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL6A2 FBXL7 ANK2 VCAN LRP1 ZNF521 ADGRG4	1.69e-07	200	90	7	74e74123ea7bf38d337a3a0248a6a51437c6ab42
ToppCell	control-HLA-DR-_S100A+_Monocyte\|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	BAZ2B VCAN LRP1 RTN3 SCPEP1 ZSWIM6 LYST	1.69e-07	200	90	7	9e3e13a68bc1110fa000ec2d80f4c654ddbce17e
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CELSR1 LMO7 MUC16 MUC5B MUC4 MUC5AC	8.63e-07	159	90	6	60b1f4dce2ce0911160fda17f137c064da31e2eb
ToppCell	droplet-Marrow-nan-21m-Hematologic-erythroid_progenitor\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZBTB49 KLF8 CELSR1 LMO7 CD86 ZNF507	9.63e-07	162	90	6	d0ffebf5adee8a3ac9b81a4b793184f54010489a
ToppCell	Adult-Epithelial-lung_goblet_cell-D175\|Adult / Lineage, Cell type, age group and donor	SPTBN2 MUC16 MUC5B ECE1 MUC4 MUC5AC	1.03e-06	164	90	6	6e6aedb61f8e195d52e028fdda750a29bb14e57e
ToppCell	15-Airway-Epithelial-Club-like_secretory\|Airway / Age, Tissue, Lineage and Cell class	CELSR1 KLF1 SPTBN2 BEST3 MUC16 MUC4	1.28e-06	170	90	6	1418031cc4b4a87a48621eb53a3c819cd713ddd0
ToppCell	Control-Epithelial_cells-ECM-high_epithelial\|Control / group, cell type (main and fine annotations)	HEG1 SHANK2 KLF1 LMO7 CNKSR3 NCKAP5	1.28e-06	170	90	6	e2023d66e70983c87dacbd6181d3426488d1fc57
ToppCell	facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PCLO KIAA1549 BEST3 HERC1 MUC4 DOP1A	1.46e-06	174	90	6	f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LMO7 BAZ2B MUC16 MUC5B MUC4 MUC5AC	1.72e-06	179	90	6	6e965e424eebef50f0202cff75f458be395cfca1
ToppCell	Children_(3_yrs)-Epithelial-lung_goblet_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CELSR1 SHANK2 MUC16 MUC5B MUC4 MUC5AC	1.89e-06	182	90	6	3f1a666fe27dd7529c114539ed5f6b8ca585c875
ToppCell	Epithelial-lung_goblet_cell\|World / Lineage, Cell type, age group and donor	CELSR1 SHANK2 MUC16 MUC5B MUC4 MUC5AC	1.96e-06	183	90	6	940cbe298e9c53b5622af09264586ed823d3141f
ToppCell	Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	COL6A2 PHLDB1 SEMA6D VCAN ECE1 VCL	2.08e-06	185	90	6	e58a009aaf342be019a909747b1895d5987d4daf
ToppCell	AT1_cells-SSc-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	ANK2 LMO7 NCKAP5 ECE1 MUC3A VCL	2.22e-06	187	90	6	f1dda349335e08dbfc8395d373924037f5ad2fd6
ToppCell	pdx-Tumor_cells-T5\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	FBXL7 VCAN CD44 ZNF521 TAF4B CCDC33	2.22e-06	187	90	6	7e376831a11ee72ed87abcdac631ca46ae29c250
ToppCell	COVID-19-lung-Secretory\|lung / Disease (COVID-19 only), tissue and cell type	CELSR1 SHANK2 LMO7 MUC5B MUC4 MUC5AC	2.36e-06	189	90	6	84d48e3ed25bebb8bb8074b3a2c5e2e88cff7f25
ToppCell	Adult-Mesenchymal-matrix_fibroblast_2_cell\|Adult / Lineage, Cell type, age group and donor	COL6A2 FBXL7 ANK2 GLI3 ZNF521 ADGRG4	2.58e-06	192	90	6	d21f0f577156f17c899b08871046a26b88aea011
ToppCell	Control-NK_CD56bright\|Control / Disease condition and Cell class	CELSR1 BAZ2B PLCH2 CD44 ZNF521 LYST	2.66e-06	193	90	6	8b1e7a226a6057e1097c1525984127b54e823876
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	USP2 COL6A2 PHLDB1 FBXL7 GLI3 ECE1	2.66e-06	193	90	6	261cafc167c86ab277be4ea7f08b0173e2dde26e
ToppCell	severe-Myeloid-CD16_Monocytes\|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	HEG1 CD86 CD101 LRP1 SDC3 TMPO	2.74e-06	194	90	6	1b33248b8a7cb914783bcf9e6a80481b4db7e0e8
ToppCell	(5)_Fibroblasts-(5)_Fibroblast-J_(Lipofibroblast)\|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4)	ANK2 GLI3 PCLO KCTD8 NR4A2 MUC16	2.74e-06	194	90	6	784b15119c91ace33d34bfb3d68c182566a3e9a8
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HEG1 FBXL7 BAZ2B ZNF521 NCKAP5 ECE1	2.74e-06	194	90	6	0b9cd96fa0b616da7cc90e92ff71157e9bba518f
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	USP2 COL6A2 PHLDB1 FBXL7 ANK2 GLI3	2.82e-06	195	90	6	ff0aa455e9844a6d7ae57ff59fb6cea825cf1fc2
ToppCell	RA-02._Fibroblast_II\|RA / Chamber and Cluster_Paper	COL6A2 PHLDB1 FBXL7 VCAN LRP1 ECE1	2.82e-06	195	90	6	6a02ebbeb3199447ddce64d92d8809436e040eba
ToppCell	COPD-Epithelial-Club\|Epithelial / Disease state, Lineage and Cell class	SEMA6D LMO7 NCKAP5 ZSWIM6 TAF4B MUC4	2.91e-06	196	90	6	af96fb94886e9395f3e2cd0a293af29229d017fe
ToppCell	COVID-19-Fibroblasts-Intermediate_pathological_FB\|COVID-19 / group, cell type (main and fine annotations)	COL6A2 MXRA5 FBXL7 GLI3 VCAN ZNF521	2.99e-06	197	90	6	f1c8936986123a3151140c374fcd62d6705c530b
ToppCell	10x3'2.3-week_17-19-Mesenchymal_adipo\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	COL6A2 MXRA5 SEMA6D VCAN LRP1 NCKAP5	2.99e-06	197	90	6	5afddde4e2b5cd55abe11e9b9efae02dbdc3da3a
ToppCell	Parenchymal-NucSeq-Endothelial-Endothelia_vascular-VE_pulmonary_venous\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	HEG1 FBXL7 KCTD8 ZNF521 ECE1 LYST	2.99e-06	197	90	6	b0036cf3f7e6edf8e43f16cd2f0f0e80471d2576
ToppCell	10x3'2.3-week_17-19-Mesenchymal_adipo-stroma-adipo-CAR\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	COL6A2 MXRA5 SEMA6D VCAN LRP1 NCKAP5	2.99e-06	197	90	6	1baffd087ca194a7355fefbb3bf67befb14fe2de
ToppCell	Bronchial-NucSeq-Epithelial-Epi_airway_basal-Basal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CELSR1 ASXL3 GLI3 PLCH2 ECE1 MUC4	2.99e-06	197	90	6	1e915957ea6a4550ecb9d6ee4b232aa5800faf20
ToppCell	10x3'2.3-week_17-19-Mesenchymal_adipo-stroma\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	COL6A2 MXRA5 SEMA6D VCAN LRP1 NCKAP5	2.99e-06	197	90	6	b9745e382baa2725dfcae060701fb53f6c8a31fa
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Myeloid-Monocytic-Classical_Monocyte-Mono_c3-CD14-VCAN\|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CD86 VCAN LRP1 RTN3 SCPEP1 LYST	2.99e-06	197	90	6	928d70af7b990300be69a4debce6e66b556e5d9f
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Myeloid-Monocytic-Classical_Monocyte\|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CD86 VCAN LRP1 RTN3 SCPEP1 LYST	2.99e-06	197	90	6	0050da0d809075fde3a7f17894dbb410b254988c
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CD86 VCAN LRP1 RTN3 SCPEP1 LYST	3.08e-06	198	90	6	110f7ebb3e1ec19508d4d2b973e1f64e7bdbb5b5
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_airway_secretory\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CELSR1 SHANK2 LMO7 NCKAP5 MUC4 MUC5AC	3.08e-06	198	90	6	af399569c718f5fd971d73a7926768c9311002a3
ToppCell	severe-HLA-DR+_CD83+_Monocyte\|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	MUC17 BAZ2B VCAN LRP1 ZSWIM6 LYST	3.08e-06	198	90	6	a77f3440d7fb6a50066abc7e9ad59e83798ef13d
ToppCell	(0)_Myeloid-(00)_Monocyte\|(0)_Myeloid / immune cells in Peripheral Blood (logTPM normalization)	VCAN CD44 LRP1 RTN3 SCPEP1 LYST	3.08e-06	198	90	6	9c17589ef0f6583c4c106c06936877fd74c258ce
ToppCell	systemic_lupus_erythematosus-flare-Myeloid\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	CD86 VCAN LRP1 RTN3 SCPEP1 LYST	3.08e-06	198	90	6	189346c5eb715f3be427bec3b8e067ababb5b475
ToppCell	BL-critical-LOC-Epithelial-Secretory_LYPD2\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	LMO7 PCLO MUC16 MUC5B MUC4 MUC5AC	3.08e-06	198	90	6	484d16aaa601a1e11b871b0475dd01a2de1a29ce
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Monocytic\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CD86 VCAN LRP1 RTN3 SCPEP1 LYST	3.08e-06	198	90	6	b19a089eb80af3428891f2ff00e53a6e11894fa3
ToppCell	healthy_donor-Myeloid-Monocytic\|healthy_donor / Disease condition, Lineage, Cell class and subclass	CD86 VCAN LRP1 RTN3 SCPEP1 LYST	3.17e-06	199	90	6	bd66a8d1a7cc92313328acc7c7ae0442faff951e
ToppCell	Fibroblasts-CD34+_Fibroblasts\|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	COL6A2 MXRA5 ANK2 GLI3 VCAN LRP1	3.17e-06	199	90	6	13ff7409e200a0b46cdb7924d15ef33639693622
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	COL6A2 MXRA5 ANK2 VCAN LRP1 SDC3	3.17e-06	199	90	6	e1849505b92820a219c5a2c35492bdd55579fb48
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	COL6A2 MXRA5 ANK2 VCAN LRP1 SDC3	3.17e-06	199	90	6	8b86c69aaf60feff53aa782559cfece7342a23de
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_adventitial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL6A2 PHLDB1 FBXL7 ANK2 VCAN LRP1	3.27e-06	200	90	6	ad3fdcef895400f929f2ae12ff9bd85fd46adb3a
ToppCell	Bronchial-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL6A2 FBXL7 ANK2 VCAN LRP1 ZNF521	3.27e-06	200	90	6	389cc775c8419d90fb77cd794376d2160a7bf44e
ToppCell	mLN-Macrophage-LYVE1_Macrophage\|Macrophage / Region, Cell class and subclass	CD86 LRP1 RTN3 SCPEP1 HERC1 SON	3.27e-06	200	90	6	e3c15e0e1c2602b0cc9ab8cc50c978d265350c94
ToppCell	Tracheal-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CELSR1 SHANK2 LMO7 PCLO MUC16 MUC5B	3.27e-06	200	90	6	d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL6A2 FBXL7 ANK2 VCAN LRP1 ZNF521	3.27e-06	200	90	6	cae972324d1dfea6efeaf6013f265c7c6bb48db4
ToppCell	Tracheal-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL6A2 FBXL7 ANK2 VCAN LRP1 ZNF521	3.27e-06	200	90	6	c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b
ToppCell	LPS_IL1RA_TNF-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	TAOK2 HEG1 BAZ2B ZNF521 NCKAP5 ECE1	3.27e-06	200	90	6	b2d4e6f3e8e4da62e6b02758ab2ed8f505269f9a
ToppCell	control-Neutrophil\|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	BAZ2B CD86 VCAN LRP1 RTN3 SCPEP1	3.27e-06	200	90	6	b5d197472799cc61d7497faed91ac2564ae4930a
ToppCell	NS-control\|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CELSR1 LMO7 PCLO MUC16 SCPEP1 MUC4	3.27e-06	200	90	6	ecbe89ff95d046155b984c8c150e0b9e7278f839
ToppCell	3'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL6A2 MXRA5 BAZ2B VCAN LRP1 NCKAP5	3.27e-06	200	90	6	ac8a5d71acd4d401995babd233f0d3738e8ad2a5
ToppCell	VE-CD8-exh_CD4\|VE / Condition, Cell_class and T cell subcluster	CD101 KIAA1549 MUC16 DTHD1 IL2RG	7.80e-06	134	90	5	4413fec495907184b6d5cf4bda39359506b2c172
ToppCell	356C-Lymphocytic-NK_cells-NK_cell_A2\|356C / Donor, Lineage, Cell class and subclass (all cells)	KLF1 GYPB TMEM63C KIAA1549 LY9	1.35e-05	150	90	5	6bdf9df586f348641a25a445e83a41e47e7f347e
ToppCell	wk_20-22-Epithelial-Proximal_epithelial-SMG_basal_1\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	SHANK2 SPTBN2 MUC5B SLC29A2 MGAM2	1.73e-05	158	90	5	adad97e6cf479d42791c5ba9cbc5f15f469322bf
ToppCell	Children_(3_yrs)-Epithelial-lung_goblet_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CELSR1 SHANK2 MUC16 MUC5B MUC4	1.90e-05	161	90	5	2d63b279d9a5132e1c09b03930bf9039036d24a2
ToppCell	368C-Fibroblasts-Fibroblast-J_(Lipofibroblast)\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	SHANK2 PCLO SPTBN2 KCTD8 MUC16	2.33e-05	168	90	5	e870d2e69316406f45112ed0bf324b24f902a99e
ToppCell	368C-Fibroblasts-Fibroblast-J_(Lipofibroblast)-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	SHANK2 PCLO SPTBN2 KCTD8 MUC16	2.33e-05	168	90	5	403aba73a0f9ffb32252288d075fad8a588ca440
ToppCell	droplet-Liver-LIVER_NPC-30m-Myeloid-Kupffer_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HEG1 CD44 SDC3 LY9 MUC4	2.46e-05	170	90	5	a121e10099faaeb60251eec162f38caf7c4238c2
ToppCell	facs-Heart-RV-18m-Mesenchymal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A2 PHLDB1 KLF1 APBA2 LRP1	2.46e-05	170	90	5	d7c9a604311974ff87ece43a0f8725a234d262f7
ToppCell	Control-Epithelial_cells-Airway_basal\|Control / group, cell type (main and fine annotations)	CELSR1 GLI3 PLCH2 ECE1 MUC4	2.53e-05	171	90	5	3965ced4be6db14265a90673502fceee425837ca
ToppCell	5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TMEM63C MUC16 MUC4 MUC5AC VCL	2.75e-05	174	90	5	42f2ba54b4ea4c62482582b0ccdadffae0a5eb4a
ToppCell	Adult-Epithelial-lung_goblet_cell-D231\|Adult / Lineage, Cell type, age group and donor	ASXL3 MUC16 MUC5B ECE1 MUC5AC	2.75e-05	174	90	5	7d2f802f493f19a068e097b2909a9000e2160266
ToppCell	Adult-Endothelial-endothelial_cell_of_vein-D231\|Adult / Lineage, Cell type, age group and donor	HEG1 FBXL7 KCTD8 ZNF521 ECE1	2.75e-05	174	90	5	2dd647c4fdf99fd1f7b838efef01baf2cbc3446d
ToppCell	facs-Heart-RV-18m-Mesenchymal-fibroblast_of_cardiac_tissue\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A2 PHLDB1 KLF1 APBA2 LRP1	2.91e-05	176	90	5	c0a084f7a8645262d61971f094689e02bf15b113
ToppCell	facs-Heart-RV-18m-Mesenchymal-fibroblast_of_cardiac_tissue\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A2 PHLDB1 KLF1 APBA2 LRP1	2.91e-05	176	90	5	cccf9201f6e2da7524b911a5961d3b227edab222
ToppCell	Club_cells-IPF_02\|World / lung cells shred on cell class, cell subclass, sample id	PLCH2 SPTBN2 TMEM63C ECE1 MUC4	2.91e-05	176	90	5	88c4ed0ab4a4ede8cad21385d799b723b5786cd9
ToppCell	BAL-Severe-Epithelial-Epithelial-undefined_Epi-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	LMO7 MUC16 MUC5B MUC4 MUC5AC	3.07e-05	178	90	5	9a3ef66814dfca7b37024e7f79e86ea8c72ae10f
ToppCell	3'_v3-Lung-Myeloid_Mac-Erythrophagocytic_macrophages\|Lung / Manually curated celltypes from each tissue	MUC17 BEST3 SDC3 MUC3A MGAM2	3.07e-05	178	90	5	b63cee443cc1b7416112bf610d7c9d41e4fa37ed
ToppCell	BAL-Severe-Epithelial-Epithelial-undefined_Epi-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	LMO7 MUC16 MUC5B MUC4 MUC5AC	3.07e-05	178	90	5	b413a634283550fa224db7d0d05956e3f64694a1
ToppCell	BAL-Severe-Epithelial-Epithelial-undefined_Epi\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	LMO7 MUC16 MUC5B MUC4 MUC5AC	3.07e-05	178	90	5	49a2271718637522f74334068d252963ee13b1ce
ToppCell	BAL-Severe-Epithelial-Epithelial-undefined_Epi\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	LMO7 MUC16 MUC5B MUC4 MUC5AC	3.07e-05	178	90	5	19b5432aa1d7f616d58a106543c18cf2d7ca840c
ToppCell	Adult-Epithelial-lung_goblet_cell\|Adult / Lineage, Cell type, age group and donor	CELSR1 MUC16 MUC5B ECE1 MUC5AC	3.15e-05	179	90	5	1fc1f252ca943a2f649d1e627f56acbf15f8e058
ToppCell	Children_(3_yrs)-Epithelial-club_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CELSR1 SHANK2 SEMA6D NCKAP5 MUC4	3.24e-05	180	90	5	b509c7d6bdfba672065fb722874bdc68de72ba1c
ToppCell	Ciliated_cells-A-Donor_07\|World / lung cells shred on cell class, cell subclass, sample id	MUC16 MUC5B DTHD1 MUC4 MUC5AC	3.24e-05	180	90	5	d9be152773fe9f2160edad9246fa03c03afeafd6
ToppCell	RA-01._Fibroblast_I\|World / Chamber and Cluster_Paper	COL6A2 PHLDB1 FBXL7 VCAN ECE1	3.32e-05	181	90	5	2b6ddeb53a79a658e2ba78527ff48c155b20daa6
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-3m-Epithelial-neuronal_stem_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VCAN CNKSR3 APBA2 KIAA1549 NCKAP5	3.32e-05	181	90	5	4e81ec1580e9acb22c32c465eb46f83d1e9e424e
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-3m-Epithelial\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VCAN CNKSR3 APBA2 KIAA1549 NCKAP5	3.32e-05	181	90	5	ad30c01290fb98adbd0caed301a584761212c977
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-3m-Epithelial-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VCAN CNKSR3 APBA2 KIAA1549 NCKAP5	3.32e-05	181	90	5	3a3268a4dff8ffcb79e09f46490e138c96f8d916
ToppCell	Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-OPC\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PHLDB1 VCAN BEST3 SDC3 NCKAP5	3.41e-05	182	90	5	8a8b08ac4bb3cba3541dbe234e088703842285b9
ToppCell	Children_(3_yrs)-Epithelial-club_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CELSR1 SHANK2 LMO7 NCKAP5 MUC4	3.41e-05	182	90	5	215c303df42f13597b2c7a95cb157c6bc7aca9a1
ToppCell	Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	COL6A2 PHLDB1 SEMA6D VCAN ECE1	3.41e-05	182	90	5	ed6ae0fd8653f213fe29906a6a4e0729a62e1b75
ToppCell	Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PHLDB1 VCAN BEST3 SDC3 NCKAP5	3.41e-05	182	90	5	e36766309c4d96a90d213ce37d3acef1029a3fdc
Drug	Famotidine [76824-35-6]; Down 200; 11.8uM; PC3; HT_HG-U133A	TAOK2 FBXL7 SMG7 LMO7 VCAN NR4A2 LRP1 ECE1 CHMP1A	7.82e-08	199	88	9	6665_DN
Drug	Nefopam hydrochloride [23327-57-3]; Down 200; 13.8uM; HL60; HT_HG-U133A	CCNT1 SMG7 CD44 NR4A2 ECE1 IL2RG DOP1A CHMP1A	8.97e-07	195	88	8	2355_DN
Drug	Salbutamol [18559-94-9]; Down 200; 16.8uM; HL60; HT_HG-U133A	HEG1 KLF1 CD44 NR4A2 PPIL2 TAF4B SLC29A2 CHMP1A	9.33e-07	196	88	8	2344_DN
Drug	Ethambutol dihydrochloride [1070-11-7]; Down 200; 14.4uM; MCF7; HT_HG-U133A	HEG1 R3HCC1L SEMA6D PCLO APBA2 PPIL2 TAF4B GOSR2	9.33e-07	196	88	8	4120_DN
Drug	Ethamsylate [2624-44-4]; Down 200; 15.2uM; HL60; HT_HG-U133A	TRAPPC11 HEG1 CD86 VCAN CD44 PPIL2 GOSR2 CNOT4	9.69e-07	197	88	8	2915_DN
Drug	0173570-0000 [211245-44-2]; Up 200; 10uM; MCF7; HT_HG-U133A	PHLDB1 PCLO NR4A2 MUC5B TAF4B CNOT4 VCL	1.00e-05	193	88	7	4712_UP
Drug	Megestrol acetate [595-33-5]; Down 200; 10.4uM; PC3; HT_HG-U133A	FBXL7 CD101 SPTBN2 LRP1 PPIL2 GOSR2 CNOT4	1.04e-05	194	88	7	6667_DN
Drug	Pirenzepine dihydrochloride [29868-97-1]; Down 200; 9.4uM; MCF7; HT_HG-U133A	FBXL7 NR4A2 APBA2 SDC3 PPIL2 ECE1 GOSR2	1.07e-05	195	88	7	2234_DN
Drug	Progesterone [57-83-0]; Up 200; 12.8uM; HL60; HT_HG-U133A	SEMA6D ANK2 PCLO CD44 APBA2 PPIL2 CCDC33	1.07e-05	195	88	7	2426_UP
Drug	AG-028671 [847803-03-6]; Up 200; 10uM; PC3; HT_HG-U133A	CCNT1 BAZ2B PLCH2 LRP1 PPIL2 MUC5B ECE1	1.07e-05	195	88	7	6557_UP
Drug	guanidine hydrochloride	COL6A2 MUC3B VCAN MUC3A MUC4 MUC5AC	1.09e-05	129	88	6	CID000005742
Drug	Benzathine benzylpenicillin [5928-84-7]; Up 200; 4.2uM; PC3; HT_HG-U133A	HEG1 LMO7 GYPB TMPO IL2RG CNOT4 DOP1A	1.11e-05	196	88	7	4022_UP
Drug	Nefopam hydrochloride [23327-57-3]; Up 200; 13.8uM; MCF7; HT_HG-U133A	PHLDB1 FBXL7 GYPB CD101 APBA2 PPIL2 ECE1	1.11e-05	196	88	7	4752_UP
Drug	Repaglinide [135062-02-1]; Up 200; 8.8uM; MCF7; HT_HG-U133A	USP2 LMO7 VCAN CD101 NR4A2 ECE1 CNOT4	1.11e-05	196	88	7	3558_UP
Drug	chlorpromazine hydrochloride; Down 200; 1uM; MCF7; HT_HG-U133A	CCNT1 PHLDB1 CD44 NR4A2 APBA2 SDC3 PPIL2	1.11e-05	196	88	7	5577_DN
Drug	Sulfamethizole [144-82-1]; Up 200; 14.8uM; MCF7; HT_HG-U133A	PHLDB1 SHANK2 ANK2 PCLO VCAN MUC5B LY9	1.15e-05	197	88	7	6099_UP
Drug	Promazine hydrochloride [53-60-1]; Down 200; 12.4uM; PC3; HT_HG-U133A	COL6A2 R3HCC1L VCAN APBA2 TMPO PPIL2 TAF4B	1.15e-05	197	88	7	3752_DN
Drug	fludrocortisone acetate; Up 200; 1uM; MCF7; HG-U133A	SMG7 CD44 APBA2 TMPO PPIL2 GOSR2 SLC29A2	1.15e-05	197	88	7	281_UP
Drug	0173570-0000 [211245-44-2]; Up 200; 1uM; MCF7; HT_HG-U133A	TAOK2 PHLDB1 SMG7 KLF1 PPIL2 MUC5B LY9	1.15e-05	197	88	7	4715_UP
Drug	Orlistat; Down 200; 10uM; MCF7; HT_HG-U133A	TAOK2 R3HCC1L SHANK2 SDC3 IL2RG CNOT4 CCDC33	1.15e-05	197	88	7	6383_DN
Drug	Dilazep dihydrochloride [20153-98-4]; Down 200; 6uM; HL60; HT_HG-U133A	TAOK2 VCAN CD44 PPIL2 LY9 ECE1 GOSR2	1.18e-05	198	88	7	2333_DN
Drug	Nafcillin sodium salt monohydrate [7177-50-6]; Up 200; 8.8uM; MCF7; HT_HG-U133A	TAOK2 COL6A2 HEG1 CD44 NR4A2 ECE1 MUC5AC	1.18e-05	198	88	7	3323_UP
Drug	Diperodon hydrochloride [537-12-2]; Down 200; 9.2uM; PC3; HT_HG-U133A	TAOK2 HEG1 CD101 NR4A2 LRP1 SDC3 PPIL2	1.18e-05	198	88	7	4498_DN
Drug	Corticosterone [50-22-6]; Up 200; 11.6uM; MCF7; HT_HG-U133A	KLF8 PHLDB1 GYPB VCAN NR4A2 APBA2 MUC4	1.18e-05	198	88	7	4145_UP
Drug	Pentylenetetrazole [54-95-5]; Up 200; 29uM; MCF7; HT_HG-U133A	TAOK2 SHANK2 VCAN SDC3 PPIL2 IL2RG CNOT4	1.18e-05	198	88	7	2255_UP
Drug	(1-[(4-Chlorophenyl)phenyl-methyl]-4-methylpiperazine) [1620-21-9]; Up 200; 11.8uM; PC3; HT_HG-U133A	USP2 MXRA5 SHANK2 PLCH2 CD101 NR4A2 MUC5AC	1.18e-05	198	88	7	3810_UP
Drug	Zimelidine dihydrochloride monohydrate [61129-30-4]; Up 200; 9.8uM; MCF7; HT_HG-U133A	TAOK2 FBXL7 CD44 APBA2 SDC3 PPIL2 TAF4B	1.18e-05	198	88	7	1512_UP
Drug	Glycopyrrolate [596-51-0]; Up 200; 10uM; PC3; HT_HG-U133A	FBXL7 R3HCC1L NR4A2 LRP1 PPIL2 ECE1 CNOT4	1.18e-05	198	88	7	7386_UP
Drug	A-Cw	LRBA LYST VCL	1.20e-05	12	88	3	CID013891726
Drug	CAY10397; Down 200; 10uM; PC3; HT_HG-U133A	SHANK2 VCAN NR4A2 SDC3 ECE1 GOSR2 POLR3C	1.22e-05	199	88	7	7071_DN
Drug	Sulfanilamide [63-74-1]; Up 200; 23.2uM; HL60; HT_HG-U133A	COL6A2 MXRA5 FBXL7 PLCH2 SPTBN2 LRP1 CNOT4	1.22e-05	199	88	7	2709_UP
Drug	Graveoline [485-61-0]; Up 200; 14.4uM; MCF7; HT_HG-U133A	USP2 PHLDB1 MXRA5 SHANK2 LMO7 IL2RG VCL	1.22e-05	199	88	7	3614_UP
Drug	Spironolactone [52-01-7]; Down 200; 9.6uM; PC3; HT_HG-U133A	HEG1 FBXL7 R3HCC1L VCAN NR4A2 GOSR2 CNOT4	1.22e-05	199	88	7	5781_DN
Drug	Alfuzosin hydrochloride [81403-68-1]; Down 200; 9.4uM; MCF7; HT_HG-U133A	USP2 GLI3 SDC3 SCPEP1 PPIL2 GOSR2 LYST	1.22e-05	199	88	7	3203_DN
Drug	cellobiitol	MUC3B MUC3A MUC4 MUC5AC	1.25e-05	37	88	4	CID000003871
Drug	Lanatoside C [17575-22-3]; Up 200; 4uM; MCF7; HT_HG-U133A	CCNT1 NR4A2 CNOT4 VCL SON SLC35F5	4.24e-05	164	88	6	3852_UP
Drug	S-23	IL2RG LYST	4.42e-05	3	88	2	CID000151186
Drug	Sch 32615	CD44 TMPO ECE1	6.06e-05	20	88	3	CID005486715
Drug	prochlorperazine dimaleate salt; Up 200; 10uM; HL60; HT_HG-U133A	HEG1 SHANK2 CD86 VCAN NR4A2 DOP1A	7.34e-05	181	88	6	2675_UP
Drug	Levonordefrin [829-74-3]; Up 200; 21.8uM; HL60; HT_HG-U133A	TAOK2 HEG1 FBXL7 CD86 NR4A2 PPIL2	7.80e-05	183	88	6	2710_UP
Drug	Prenylamine lactate [69-43-2]; Up 200; 9.6uM; HL60; HG-U133A	SMG7 CD101 NR4A2 TMPO ECE1 CNOT4	8.03e-05	184	88	6	1737_UP
Drug	Dobutamine hydrochloride [49745-95-1]; Up 200; 11.8uM; PC3; HT_HG-U133A	PHLDB1 VCAN NR4A2 MUC5B MUC5AC CNOT4	8.28e-05	185	88	6	6286_UP
Drug	ICI182,780; Down 200; 1uM; MCF7; HT_HG-U133A	R3HCC1L SMG7 CD44 ECE1 GOSR2 CNOT4	8.78e-05	187	88	6	6872_DN
Drug	IAA-94	CACNG7 GLI3 BEST3 IL2RG	9.19e-05	61	88	4	CID000003667
Drug	Clioquinol [130-26-7]; Up 200; 13uM; HL60; HT_HG-U133A	SHANK2 PCLO CD44 NR4A2 PPIL2 GOSR2	9.31e-05	189	88	6	3084_UP
Drug	daunorubicin HCl; Down 200; 1uM; MCF7; HT_HG-U133A	BAZ2B SPTBN2 TMPO PPIL2 SLC29A2 SON	9.87e-05	191	88	6	7525_DN
Drug	Chlorprothixene hydrochloride [6469-93-8]; Up 200; 11.4uM; MCF7; HT_HG-U133A	TAOK2 CD86 SPTBN2 NR4A2 APBA2 PPIL2	9.87e-05	191	88	6	2627_UP
Drug	Isotretinoin [4759-48-2]; Down 200; 13.4uM; MCF7; HT_HG-U133A	TAOK2 CCNT1 PHLDB1 CD44 PPIL2 ECE1	9.87e-05	191	88	6	7438_DN
Drug	Dimethisoquin hydrochloride [2773-92-4]; Up 200; 13uM; MCF7; HT_HG-U133A	HEG1 CD86 GYPB NR4A2 LRP1 TAF4B	9.87e-05	191	88	6	4791_UP
Drug	Ethisterone [434-03-7]; Down 200; 12.8uM; MCF7; HT_HG-U133A	KLF8 SHANK2 SEMA6D LMO7 MUC5B CNOT4	9.87e-05	191	88	6	3975_DN
Drug	Pramoxine hydrochloride [637-58-1]; Down 200; 12.2uM; MCF7; HT_HG-U133A	USP2 PHLDB1 R3HCC1L SPTBN2 GOSR2 CNOT4	1.02e-04	192	88	6	6054_DN
Drug	WY-14643; Down 200; 100uM; PC3; HG-U133A	TRAPPC11 PHLDB1 SHANK2 CD44 PPIL2 VCL	1.02e-04	192	88	6	464_DN
Drug	STOCK1N-28457; Down 200; 20uM; MCF7; HT_HG-U133A	R3HCC1L CD44 APBA2 MUC5B ECE1 GOSR2	1.04e-04	193	88	6	6869_DN
Drug	Azacyclonol [115-46-8]; Up 200; 15uM; MCF7; HT_HG-U133A	KLF8 FBXL7 LMO7 APBA2 PPIL2 ECE1	1.07e-04	194	88	6	5398_UP
Drug	Salsolinol hydrobromide [38221-21-5]; Down 200; 15.4uM; PC3; HT_HG-U133A	TAOK2 VCAN LRP1 SCPEP1 ECE1 GOSR2	1.07e-04	194	88	6	4232_DN
Drug	Ketoconazole [65277-42-1]; Up 200; 7.6uM; PC3; HT_HG-U133A	PHLDB1 SEMA6D VCAN NR4A2 LY9 CNOT4	1.07e-04	194	88	6	4624_UP
Drug	Zomepirac sodium salt [64092-48-4]; Down 200; 12.8uM; MCF7; HT_HG-U133A	SMG7 CD44 TMPO PPIL2 TAF4B CNOT4	1.07e-04	194	88	6	3454_DN
Drug	Quinethazone [73-49-4]; Down 200; 13.8uM; PC3; HT_HG-U133A	CELSR1 NR4A2 SDC3 MUC5B GOSR2 SLC29A2	1.07e-04	194	88	6	4529_DN
Drug	Tolbutamide [64-77-7]; Up 200; 14.8uM; PC3; HT_HG-U133A	SHANK2 SEMA6D SMG7 MUC4 LYST DOP1A	1.11e-04	195	88	6	3804_UP
Drug	SB 202190; Down 200; 1uM; PC3; HT_HG-U133A	TAOK2 CCNT1 SMG7 LMO7 VCAN TMPO	1.11e-04	195	88	6	7058_DN
Drug	Atropine sulfate monohydrate [5908-99-6]; Up 200; 5.8uM; MCF7; HT_HG-U133A	TAOK2 PHLDB1 FBXL7 APBA2 GOSR2 CNOT4	1.11e-04	195	88	6	7219_UP
Drug	Idazoxan hydrochloride [79944-56-2]; Up 200; 16.6uM; MCF7; HT_HG-U133A	SPTBN2 CD44 APBA2 TAF4B LY9 CNOT4	1.11e-04	195	88	6	6465_UP
Drug	Methylhydantoin-5-(L) [40856-73-3]; Up 200; 35uM; MCF7; HT_HG-U133A	SEMA6D LMO7 CD101 APBA2 ECE1 MUC5AC	1.11e-04	195	88	6	3378_UP
Drug	Nitrarine dihydrochloride [20069-05-0]; Up 200; 10.6uM; MCF7; HT_HG-U133A	SMG7 KLF1 SPTBN2 TAF4B MUC4 CNOT4	1.11e-04	195	88	6	4705_UP
Drug	Sulfachloropyridazine [80-32-0]; Down 200; 14uM; PC3; HT_HG-U133A	TAOK2 HEG1 VCAN CD101 LRP1 PPIL2	1.11e-04	195	88	6	4326_DN
Drug	Adenosine 5'-monophosphate monohydrate [18422-05-4]; Down 200; 11uM; MCF7; HT_HG-U133A	TAOK2 USP2 R3HCC1L TMPO TAF4B CNOT4	1.11e-04	195	88	6	3237_DN
Drug	3-Acetylcoumarin [3949-36-8]; Down 200; 21.2uM; PC3; HT_HG-U133A	TAOK2 PHLDB1 FBXL7 SPTBN2 PPIL2 CNOT4	1.11e-04	195	88	6	4664_DN
Drug	Amiprilose hydrochloride [60414-06-4]; Up 200; 11.8uM; PC3; HT_HG-U133A	PHLDB1 HEG1 CD44 LRP1 PPIL2 VCL	1.14e-04	196	88	6	4000_UP
Drug	PF-00875133-00 [351322-64-0]; Down 200; 10uM; PC3; HT_HG-U133A	SHANK2 SPTBN2 PPIL2 LY9 GOSR2 CNOT4	1.14e-04	196	88	6	5928_DN
Drug	haloperidol; Down 200; 10uM; MCF7; HG-U133A	FBXL7 GYPB SPTBN2 SDC3 PPIL2 DOP1A	1.14e-04	196	88	6	492_DN
Drug	Molindone hydrochloride [15622-65-8]; Up 200; 12.8uM; MCF7; HT_HG-U133A	FBXL7 PCLO VCAN NR4A2 APBA2 CCDC33	1.14e-04	196	88	6	4784_UP
Drug	Alcuronium chloride [15180-03-7]; Up 200; 5.4uM; MCF7; HT_HG-U133A	COL6A2 SEMA6D VCAN SPTBN2 ECE1 CCDC33	1.14e-04	196	88	6	4409_UP
Drug	Piperidolate hydrochloride [129-77-1]; Down 200; 11.2uM; MCF7; HT_HG-U133A	R3HCC1L SHANK2 SMG7 C11orf24 ECE1 CNOT4	1.14e-04	196	88	6	6772_DN
Drug	clozapine; Up 200; 10uM; MCF7; HT_HG-U133A	USP2 PHLDB1 ANK2 NR4A2 SDC3 TMPO	1.14e-04	196	88	6	5226_UP
Drug	Hymecromone [90-33-5]; Up 200; 22.8uM; PC3; HT_HG-U133A	TAOK2 PHLDB1 FBXL7 LMO7 PPIL2 MUC4	1.14e-04	196	88	6	4623_UP
Drug	Ribavirin [36791-04-5]; Up 200; 16.4uM; PC3; HT_HG-U133A	TAOK2 VCAN SPTBN2 LRP1 PPIL2 CNOT4	1.14e-04	196	88	6	7316_UP
Drug	0316684-0000 [391209-55-5]; Down 200; 10uM; PC3; HT_HG-U133A	CCNT1 SHANK2 LMO7 LRP1 PPIL2 GOSR2	1.14e-04	196	88	6	7057_DN
Drug	Xylometazoline hydrochloride [1218-35-5]; Up 200; 14.2uM; MCF7; HT_HG-U133A	TAOK2 SHANK2 GYPB VCAN SDC3 LY9	1.14e-04	196	88	6	2270_UP
Drug	Tolbutamide [64-77-7]; Down 200; 14.8uM; PC3; HT_HG-U133A	PHLDB1 FBXL7 CD101 GOSR2 CNOT4 VCL	1.14e-04	196	88	6	4540_DN
Drug	2-propylpentanoic acid; Down 200; 50uM; MCF7; HT_HG-U133A_EA	TAOK2 CCNT1 GLI3 NR4A2 GOSR2 SLC35F5	1.14e-04	196	88	6	1002_DN
Drug	Iohexol [66108-95-0]; Up 200; 4.8uM; MCF7; HT_HG-U133A	KLF1 PCLO NR4A2 PPIL2 LY9 VCL	1.14e-04	196	88	6	5704_UP
Drug	Dimethadione [695-53-4]; Up 200; 31uM; MCF7; HT_HG-U133A	KLF1 PCLO CD101 APBA2 ECE1 CNOT4	1.14e-04	196	88	6	5668_UP
Drug	Thiamine hydrochloride [67-03-8]; Up 200; 11.8uM; MCF7; HT_HG-U133A	USP2 GYPB APBA2 SDC3 PPIL2 CNOT4	1.14e-04	196	88	6	7479_UP
Drug	Terconazole [67915-31-5]; Down 200; 7.6uM; MCF7; HT_HG-U133A	TAOK2 HEG1 FBXL7 MUC5B TAF4B GOSR2	1.14e-04	196	88	6	4407_DN
Drug	Heptaminol hydrochloride [543-15-7]; Down 200; 22uM; MCF7; HT_HG-U133A	HEG1 NR4A2 APBA2 SDC3 C11orf24 SLC35F5	1.14e-04	196	88	6	6015_DN
Drug	Sulfaguanidine [57-67-0]; Down 200; 18.6uM; HL60; HG-U133A	CD86 NVL TMPO PPIL2 LRBA GOSR2	1.14e-04	196	88	6	1995_DN
Drug	Metrizamide [31112-62-6]; Up 200; 5uM; MCF7; HT_HG-U133A	TAOK2 PHLDB1 KLF1 GYPB VCAN PPIL2	1.17e-04	197	88	6	4156_UP
Drug	1-phenylbiguanide hydrochloride; Down 200; 10uM; MCF7; HG-U133A	CCNT1 MXRA5 PCLO APBA2 LRP1 PPIL2	1.17e-04	197	88	6	22_DN
Drug	Nicergoline; Down 200; 8.2uM; PC3; HT_HG-U133A	HEG1 FBXL7 LMO7 PPIL2 GOSR2 CNOT4	1.17e-04	197	88	6	5775_DN
Drug	Clofilium tosylate [92953-10-1]; Up 200; 7.8uM; MCF7; HT_HG-U133A	SEMA6D VCAN APBA2 ECE1 IL2RG MUC5AC	1.17e-04	197	88	6	6830_UP
Drug	Clonidine hydrochloride [4205-91-8]; Up 200; 15uM; PC3; HT_HG-U133A	TAOK2 HEG1 ANK2 VCAN LRP1 ECE1	1.17e-04	197	88	6	4478_UP
Drug	(-)-Adenosine 3',5'-cyclic monophosphate [60-92-4]; Up 200; 12.2uM; MCF7; HT_HG-U133A	TAOK2 HEG1 SPTBN2 APBA2 GOSR2 IL2RG	1.17e-04	197	88	6	3531_UP
Drug	Methiazole; Down 200; 15uM; MCF7; HT_HG-U133A	TAOK2 R3HCC1L SMG7 SCPEP1 PPIL2 CNOT4	1.17e-04	197	88	6	4354_DN
Drug	Benfluorex hydrochloride [23642-66-2]; Down 200; 10.4uM; PC3; HT_HG-U133A	TAOK2 PHLDB1 LRP1 PPIL2 ECE1 GOSR2	1.17e-04	197	88	6	6727_DN
Drug	Zardaverine [101975-10-4]; Up 200; 15uM; MCF7; HT_HG-U133A	FBXL7 CD101 NR4A2 APBA2 TMPO SLC35F5	1.17e-04	197	88	6	4793_UP
Drug	Dubinidine [22964-77-8]; Up 200; 14.6uM; MCF7; HT_HG-U133A	PHLDB1 HEG1 NR4A2 SDC3 GOSR2 LYST	1.17e-04	197	88	6	3554_UP
Drug	Delsoline [509-18-2]; Up 200; 8.6uM; MCF7; HT_HG-U133A	PHLDB1 HEG1 KLF1 GYPB SDC3 CNOT4	1.17e-04	197	88	6	7212_UP
Drug	Tracazolate hydrochloride [41094-88-6]; Up 200; 11.8uM; PC3; HT_HG-U133A	PHLDB1 ANK2 GYPB VCAN NR4A2 LY9	1.17e-04	197	88	6	6619_UP
Drug	Seneciphylline [480-81-9]; Up 200; 12uM; MCF7; HT_HG-U133A	ANK2 GYPB PCLO VCAN CD101 SPTBN2	1.17e-04	197	88	6	4822_UP
Drug	Dihydroergotoxine mesylate [8067-24-1]; Up 200; 6.4uM; MCF7; HT_HG-U133A	KLF8 MXRA5 PCLO VCAN NR4A2 APBA2	1.17e-04	197	88	6	4152_UP
Disease	cholangiocarcinoma (is_marker_for)	MUC16 MUC5B MUC3A MUC4 MUC5AC	1.48e-06	64	89	5	DOID:4947 (is_marker_for)
Disease	keratoconjunctivitis (is_marker_for)	MUC16 MUC5AC	2.69e-05	3	89	2	DOID:9368 (is_marker_for)
Disease	pancreatic ductal carcinoma (is_marker_for)	MUC5B MUC3A MUC4 MUC5AC	3.54e-05	61	89	4	DOID:3587 (is_marker_for)
Disease	mucinous adenocarcinoma (is_marker_for)	MUC4 MUC5AC	8.94e-05	5	89	2	DOID:3030 (is_marker_for)
Disease	biliary tract benign neoplasm (is_marker_for)	MUC4 MUC5AC	1.87e-04	7	89	2	DOID:0050625 (is_marker_for)
Disease	common bile duct neoplasm (is_marker_for)	MUC4 MUC5AC	2.49e-04	8	89	2	DOID:4608 (is_marker_for)
Disease	bladder exstrophy	CELSR1 NCKAP5 GOSR2	3.21e-04	44	89	3	MONDO_0010805
Disease	dry eye syndrome (is_marker_for)	MUC16 MUC5AC	3.98e-04	10	89	2	DOID:10140 (is_marker_for)
Disease	otitis media (is_marker_for)	MUC5B MUC4	3.98e-04	10	89	2	DOID:10754 (is_marker_for)
Disease	pulmonary fibrosis	MUC5B MUC5AC	4.86e-04	11	89	2	EFO_0009448
Disease	cortical thickness	PHLDB1 CELSR1 FBXL7 SMG7 GLI3 VCAN SPTBN2 CNKSR3 LRP1 NCKAP5 ECE1	5.19e-04	1113	89	11	EFO_0004840
Disease	idiopathic pulmonary fibrosis	MUC5B GOSR2 MUC5AC	6.90e-04	57	89	3	EFO_0000768
Disease	Pontoneocerebellar hypoplasia	PCLO CHMP1A	1.05e-03	16	89	2	cv:C1261175
Disease	nasopharyngeal neoplasm	FBXL7 R3HCC1L PCLO ZNF507	1.15e-03	151	89	4	EFO_0004252
Disease	otitis media (biomarker_via_orthology)	MUC4 MUC5AC	1.19e-03	17	89	2	DOID:10754 (biomarker_via_orthology)
Disease	anorectal malformation	ZNF507 MUC5B	1.49e-03	19	89	2	MONDO_0019938
Disease	Dermatologic disorders	CD44 NR4A2 APBA2	1.53e-03	75	89	3	C0037274
Disease	neuroticism measurement	KLF8 SEMA6D ASXL3 PCLO CNKSR3 ZNF507 NR4A2 HERC1 ECE1	1.69e-03	909	89	9	EFO_0007660
Disease	depressive symptom measurement	SEMA6D ASXL3 PCLO NR4A2 HERC1 ECE1	1.85e-03	426	89	6	EFO_0007006
Disease	Sjogren's syndrome (is_marker_for)	MUC16 MUC5AC	2.38e-03	24	89	2	DOID:12894 (is_marker_for)
Disease	blood rubidium measurement	NCKAP5 TAF4B	2.79e-03	26	89	2	EFO_0021529

Protein segments in the cluster

Peptide	Gene	Start	Entry
MSSQPALLIDTETSS	BEST3	611	Q8N1M1
TSSLSPFSTHITQLM	VCAN	1151	P13611
PFSTHITQLMEETTT	VCAN	1156	P13611
LTTPTQSEREMTDST	VCAN	1776	P13611
MTDSTPVFTETNTLE	VCAN	1786	P13611
VSSTMDLSTSTPREA	CCDC33	606	Q8N5R6
VSNLSSTTMTTALVP	ADGRG4	1051	Q8IZF6
VDTTTSSSTRISNPM	ADGRG4	1416	Q8IZF6
TSLTHADMSTASLVT	BAZ2B	1571	Q9UIF8
SSVSTSSEAIMSTEL	FAM106A	76	Q4KMX7
TISELSELTPQTDSM	GZF1	686	Q9H116
LLSTSSETIPMVVSD	DOP1A	1081	Q5JWR5
SLSMTSITSASEASP	APBA2	236	Q99767
SEESSSNLTSVEMLP	CCNT1	316	O60563
PMSSSTSVSITVLDV	CELSR1	666	Q9NYQ6
ISLSVSFPDVTSNMT	CD86	201	P42081
DSLIPSTSSMTHVSD	ASXL3	541	Q9C0F0
DLPLTSETSSVSSML	ASXL3	721	Q9C0F0
SETSSVSSMLLTSET	ASXL3	726	Q9C0F0
VSSMLLTSETTFVSS	ASXL3	731	Q9C0F0
IVSSTSSENSSVPML	ASXL3	1216	Q9C0F0
SQAETSTPRTETTMS	MUC5B	1756	Q9HC84
SLSESTNDTVSPVMI	R3HCC1L	316	Q7Z5L2
VSASFTSTAMVPETT	PPIL2	246	Q13356
EVTMTSLSSSIPEDT	PCDHGA7	346	Q9Y5G6
SNTPEMEQRETTSST	NVL	136	O15381
VPLSSRSMEISETSV	KIAA1549	491	Q9HCM3
VSSSFEPTMSATTTV	ANK2	3011	Q01484
DSMSSATTLTTPQEQ	CHMP1A	131	Q9HD42
TSSMEATSIREPSTT	MUC16	1006	Q8WXI7
DTLSATMSPTHVTQS	MUC16	1556	Q8WXI7
PVRTFSTMVSTDTAS	MUC16	2471	Q8WXI7
QSLATMSSVSLESPT	MUC16	3306	Q8WXI7
MSSVSLESPTARSIT	MUC16	3311	Q8WXI7
FTDVSTNPSTSLIMT	MUC16	4366	Q8WXI7
DTSLETVTSSPQSMS	MUC16	4791	Q8WXI7
TVTSSPQSMSNTLDD	MUC16	4796	Q8WXI7
TNTRLSTSPIMTESA	MUC16	4956	Q8WXI7
STSPIMTESAEITIT	MUC16	4961	Q8WXI7
PLMSTTSTLGDTSVS	MUC16	5451	Q8WXI7
MLDTHSELVTSSLPS	MUC16	5971	Q8WXI7
PDTSTRSVTMLSTFA	MUC16	6421	Q8WXI7
DTIVSTSMPGSSEIT	MUC16	6631	Q8WXI7
VTSLLTSSPVTTTDM	MUC16	7126	Q8WXI7
TTTDMLHTSPELVTS	MUC16	7136	Q8WXI7
STTPSLVITHSTMTQ	MUC16	7346	Q8WXI7
LSTSPIMTESAESAI	MUC16	8481	Q8WXI7
TTDMLRTSSEPETSS	MUC16	8601	Q8WXI7
LSSTSVEIPATSEIM	MUC16	9786	Q8WXI7
ETSISTSMPANFETT	MUC16	10141	Q8WXI7
TSSSPILDTRMTESV	MUC16	10391	Q8WXI7
TSRFSHSELDTMPST	MUC16	11281	Q8WXI7
SAVSTTTISPDMSDL	MUC16	11531	Q8WXI7
TTISPDMSDLVTSLV	MUC16	11536	Q8WXI7
TETSTMIPTSTLSLG	MUC16	11856	Q8WXI7
THQSSMTTTRTPDTS	MUC16	13441	Q8WXI7
PDEMTTSFPSSVTNT	MUC4	116	Q99102
TQESQTTRSVSPMTD	MUC4	646	Q99102
TSQTIISTIPSTAMH	MUC4	4286	Q99102
SSVSTSSEAIMSTEL	FAM106C	76	P0CH98
STILPISEMVSSSSS	KCTD8	11	Q6ZWB6
ETPIMDSTISTATTA	GLI3	746	P10071
VIMATTSPTSTDVAS	MGAM2	2216	Q2M2H8
ITSILSMFPTSNTFT	MGAM2	2311	Q2M2H8
TSTKDNTMSPDTTVT	MGAM2	2361	Q2M2H8
FTIASTTVPETTMAS	MUC22	141	E2RYF6
TITPTSTRQTTAMDF	LRP1	221	Q07954
MEESTTSLVSSSTSA	KIAA1109	4021	Q2LD37
FMSSSLEDTTTATTP	HERC1	2646	Q15751
EIQTVFDMEPSSTSS	TMEM63C	721	Q9P1W3
EERSSMASSPISSIS	PCLO	4016	Q9Y6V0
MTLTTSPHDTLISET	MUC3A	76	Q02505
TTETATTPMTNLVTT	MUC3A	376	Q02505
TTPMTNLVTTTTEIS	MUC3A	381	Q02505
PTTDISTVSLTTAMT	MUC3A	991	Q02505
STEMITSHTTNTTPL	MUC3A	1051	Q02505
PSIQNTETSSLVSMT	MUC3A	1241	Q02505
TETSSLVSMTSATTP	MUC3A	1246	Q02505
DFSTESLTTAMTSTP	MUC3A	1371	Q02505
SPQTLVVSTSTSDMS	KLF8	116	O95600
TSDMSTSANIPTVLT	KLF8	126	O95600
DSMTVSEVTASISSP	LRBA	1071	P50851
VLSSNSMSLTTREPS	LMO7	1281	Q8WWI1
MSTQLTIESEAPSDS	LRRC37B	771	Q96QE4
SRTFTTNDSDTTIPM	GOSR2	106	O14653
SESTPIAETIMASSN	TMPO	276	P42167
TQTTFTTHMPSASTE	MUC5AC	1701	P98088
RETPVTSFQTSTMTS	HEG1	751	Q9ULI3
SISALSTTEVAMHTS	GYPB	16	P06028
IVIPDTLSATMSSQT	CD101	141	Q93033
MATAETALPSISTLT	KLF1	1	Q13351
TDRIPATTLMSTSAT	CD44	216	P16070
SEDSDLSMRTLSTPS	FBXL7	41	Q9UJT9
LDTSESVTMQSPTDI	COL6A2	51	P12110
RSPSDISSDVSIQMT	CACNG7	241	P62955
QETSESPREEMTTSS	DTHD1	126	Q6ZMT9
FTSSTPSEIEMETQI	LYST	3596	Q99698
SEASSVTSMTHVTLL	LY9	341	Q9HBG7
FLTTMPTDSLSVSTL	IL2RG	41	P31785
SVTSSILSSMDPTVD	ECE1	106	P42892
EPSQRATTVSTTMAT	SDC3	151	O75056
MDVLLTHPSFTSEST	POLB	191	P06746
STNPEMTSIESSVTS	MUC17	86	Q685J3
SSTRMTPTESRTTSE	MUC17	106	Q685J3
TPSEESISSTMAFVS	MUC17	151	Q685J3
VATSEMSTLSITPVD	MUC17	346	Q685J3
TTAEATSMLTSTLSE	MUC17	376	Q685J3
TSMPVNTTLVASSEA	MUC17	691	Q685J3
STTMVASFETSTLST	MUC17	2346	Q685J3
VDTSTPMTTSTEASS	MUC17	2481	Q685J3
STMPVASSEASTLST	MUC17	2641	Q685J3
TEASSSPTTAEVTSM	MUC17	2786	Q685J3
TMPVASSEASTLSRT	MUC17	2996	Q685J3
LTTMPVSTTRVTSSE	MUC17	3696	Q685J3
STTVNPEAVTTMTTR	MUC17	4081	Q685J3
MTLTTSPHDTLISET	MUC3B	76	Q9H195
TPSFMSSIITTETTS	MUC3B	336	Q9H195
ITATTSLPSFSTFMD	NR4A2	51	P43354
EPSSEIMTSSFLSSS	RTN3	76	O95197
DMVIATCTTTVTTSP	TAF4B	351	Q92750
KHLTNDTTTPESTMT	TMEM248	76	Q9NWD8
SVFPAITAMVTSSTS	SLC29A2	306	Q14542
TTDTTMNSSLSEPLY	SLC35F5	151	Q8WV83
STHEPLEMTSSKSVS	NCKAP5	1071	O14513
STPTSTMESSLEFTQ	SCPEP1	276	Q9HB40
PSELMSHSSSFLSLT	SMG7	921	Q92540
TSLESSHSVPSMSIS	TAOK2	346	Q9UL54
TDSCTPITSEVSDTM	SRPK1	411	Q96SB4
SPEIMSTISGTRSTT	SHANK2	1661	Q9UPX8
ATTQSPESTMDTSLK	CNK3/IPCEF1	321	G9CGD6
ATTQSPESTMDTSLK	CNKSR3	321	Q6P9H4
TVASIAPTTAASSMT	C11orf24	141	Q96F05
EVKVSTMPLSTSSHS	CNOT4	546	O95628
TASVMASVTSLLSSP	ZNF532	396	Q9HCE3
TSTISTMRSHTQEDP	ZNF596	96	Q8TC21
TIVSSELQLAPSMTT	TRAPPC11	926	Q7Z392
LRMSEITTSSSAPFT	POLR3C	271	Q9BUI4
MSSTLSPTDFDSLEI	SPTBN2	1	O15020
SSSMSSSDTVIDLSL	PLCH2	1146	O75038
STTPDSNLSVDSSTM	ZNF521	356	Q96K83
MTQEVSDVFSDTTTP	VCL	591	P18206
TLSLESSDSMETSIS	PHLDB1	1111	Q86UU1
STLTVSNMSPEDSSI	TRBV29-1	91	A0A5B7
VSSSELMSQTPSEVL	ZNF507	861	Q8TCN5
PTEATSIVATTVMSN	ZSWIM6	946	Q9HCJ5
SFSQDTSVTLMPVSV	ZBTB49	616	Q6ZSB9
SSVTPMSSSQVRTSD	USP2	576	O75604
EVSSSSVTTMASIPE	SEMA6D	591	Q8NFY4
TMTVSQSLEVPSTTA	SON	666	P18583
PHTSITMASSDSTLR	WDR81	1751	Q562E7
DLAPSTSTTTHYIMT	ELFN2	386	Q5R3F8
TATVRLPEMSTQSAS	MXRA5	1616	Q9NR99
IPMVSSTQSSISFIT	MXRA5	1806	Q9NR99